TRIATOMIC CAPITAL

Investment Thesis

Triatomic Capital backs what it calls “century‑defining” technologies and businesses, focusing on applied AI, engineered biology, new materials, next‑gen compute, and new energy. Its thesis is that combining breakthrough science with modern AI will redefine drug discovery, materials design, and infrastructure, creating companies with both scientific and economic moats. The firm tends to lead or co‑lead seed and Series A rounds, often in technically complex companies that sit at the intersection of software and wet lab, or hardware and physics. It favors founders with deep research backgrounds and a bias to build full‑stack platforms rather than point solutions. Triatomic is highly active in AI‑for‑science, backing platforms that compress R&D timelines in chemistry, biology, and advanced manufacturing.

Notable AI Portfolio

• Manifold Bio
• Chemify
• Betteromics
• iPronics

Tags

• vc firm